KIT and cancer: Cenisertib inhibits the kinase activity of AKT as well as FLT3, VEGFR2, LYN, BTK, and KIT and promotes growth inhibition, cell cycle arrest, and apoptosis in many cancer cell lines (McLaughlin et al., 2010).